Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anita J Chawla

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Health Care Financing Review|November 6, 2014
Preventive Services for Children Under Medicaid, 1989 and 1992Elicia J Herz, Anita J Chawla, Norma I Gavin
Health Care Financing Review|November 6, 2014
Developing Performance Measures for Prescription Drug ManagementAnita J Chawla, Marjorie R Hatzmann, Stacey R Long
Managed Care Interface|June 26, 2004
Absenteeism among employees with irritable bowel syndromeChristopher Zacker, Anita J Chawla, Shaohung Wang, et al.
JCO Precision Oncology|January 7, 2022
Budget Impact Analysis of Comprehensive Genomic Profiling in Patients With Advanced Non-Small-Cell Lung CancerMichael J Harvey, Rachel Cunningham, Bethany Sawchyn, et al.
The Journal of Rheumatology|August 17, 2011
Biologic disease-modifying drug treatment patterns and associated costs for patients with rheumatoid ArthritisStephan McBride, Khaled Sarsour, Leigh Ann White, et al.
Plos One|January 24, 2022
Assessing the transition from intravenous to subcutaneous delivery of rituximab: Benefits for payers, health care professionals, and patients with lymphomaMichael J Harvey, Yi Zhong, Eric Morris, et al.
Current Medical Research and Opinion|November 24, 2018
The humanistic burden of postpartum depression: a systematic literature reviewTiffany A Moore Simas, Ming-Yi Huang, Cody Patton, et al.
Pharmacoepidemiology and Drug Safety|June 4, 2014
Estimating the incremental net health benefit of requirements for cardiovascular risk evaluation for diabetes therapiesAnita J Chawla, Daniel S Mytelka, Stephan D McBride, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Health Care Financing Review|November 6, 2014
Preventive Services for Children Under Medicaid, 1989 and 1992Elicia J Herz, Anita J Chawla, Norma I Gavin
Health Care Financing Review|November 6, 2014
Developing Performance Measures for Prescription Drug ManagementAnita J Chawla, Marjorie R Hatzmann, Stacey R Long
Managed Care Interface|June 26, 2004
Absenteeism among employees with irritable bowel syndromeChristopher Zacker, Anita J Chawla, Shaohung Wang, et al.
JCO Precision Oncology|January 7, 2022
Budget Impact Analysis of Comprehensive Genomic Profiling in Patients With Advanced Non-Small-Cell Lung CancerMichael J Harvey, Rachel Cunningham, Bethany Sawchyn, et al.
The Journal of Rheumatology|August 17, 2011
Biologic disease-modifying drug treatment patterns and associated costs for patients with rheumatoid ArthritisStephan McBride, Khaled Sarsour, Leigh Ann White, et al.
Plos One|January 24, 2022
Assessing the transition from intravenous to subcutaneous delivery of rituximab: Benefits for payers, health care professionals, and patients with lymphomaMichael J Harvey, Yi Zhong, Eric Morris, et al.
Current Medical Research and Opinion|November 24, 2018
The humanistic burden of postpartum depression: a systematic literature reviewTiffany A Moore Simas, Ming-Yi Huang, Cody Patton, et al.
Pharmacoepidemiology and Drug Safety|June 4, 2014
Estimating the incremental net health benefit of requirements for cardiovascular risk evaluation for diabetes therapiesAnita J Chawla, Daniel S Mytelka, Stephan D McBride, et al.
Pageof 1